Lipid-rich variant of pancreatic endocrine neoplasms

American Journal of Surgical Pathology

Volumn 30, Issue 2, 2006, Pages 194-200

  Singh, Rajendra ^a   Basturk, Olca ^a   Klimstra, David S ^b   Zamboni, Giuseppe ^c   Chetty, Runjan ^d   Hussain, Sanaa ^b   La Rosa, Stefano ^e   Yilmaz, Asli ^f   Capelli, Paola ^c   Capella, Carlo ^e   Cheng, Jeanette D ^a   Adsay, N Volkan ^a,g  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f UNIVERSITY OF CALGARY   (Canada)

^g HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Clear cell; Lipid rich pancreatic endocrine tumors; VHL

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; INHIBIN; MELAN A; MUCIN 6; SYNAPTOPHYSIN; LIPID; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOPSY; CELL COMPARTMENTALIZATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CYSTADENOMA; ELECTRON MICROSCOPY; ENDOCRINE TUMOR; FEMALE; GENETIC VARIABILITY; HISTOGENESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PANCREAS TUMOR; SECRETORY GRANULE; ADENOCARCINOMA; ADRENAL CORTEX CARCINOMA; DIFFERENTIAL DIAGNOSIS; KIDNEY CARCINOMA; METABOLISM; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; ENDOCRINE GLAND NEOPLASMS; FEMALE; HIPPEL-LINDAU DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPIDS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645219708     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000184819.71752.ad     Document Type: Article

References (36)

1. Adsay NV, Andea A, Basturk O, et al. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527-535.
2. Adsay V, Logani S, Sarkar F, et al. Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. Am J Surg Pathol. 2000;24:493-504.
3. Barghorn A, Komminoth P, Bachmann D, et al. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J Pathol. 2001;194:451-458.
4. Buchler P, Reber HA, Buchler M, et al. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas. 2003;26:56-64.
5. Chetty R, Asa SL. Pancreatic endocrine tumors: an update. Adv Anat Pathol. 2004;11:202-210.
6. Chetty R, Kennedy M, Ezzat S, et al. Pancreatic endocrine pathology in von Hippel-Lindau disease: an expanding spectrum of lesions. Endocr Pathol. 2004;15:141-148.
7. Goldstein J, Benharroch D, Sion-Vardy N, et al. Solid cystic and papillary tumor of the pancreas with oncocytic differentiation. J Surg Oncol. 1994;56:63-67.
8. Guarda LA, Silva EG, Ordonez NG, et al. Clear cell islet cell tumor. Am J Clin Pathol. 1983;79:512-517.
9. Hoang MP, Hruban RH, Albores-Saavedra J. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease. Am J Surg Pathol. 2001;25:602-609.
10. Hochwald SN, Zee S, Conlon KC, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol. 2002;20:2633-2642.
11. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol. 2004;22:4991-5004.
12. Klimstra DS, Adsay NV Benign and malignant tumors of the pancreas. In: Odze RD, Goldblum JR, Crawford JM, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Philadelphia: Saunders, 2003: 699-731.
13. Kosmahl M, Wagner J, Peters K, et al. Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol. 2004;28:339-346.
14. Krieg M, Haas R, Brauch H, et al. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene. 2000;19:5435-5443.
15. Lack EE. Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tract and Ampullary Region. New York: Oxford University Press, 2003:323-373.
16. Libutti SK, Choyke PL, Bartlett DL, et al. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery. 1998;124:1153-1159.
17. Lott ST, Chandler DS, Curley SA, et al. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. Cancer Res. 2002;62:1952-1955.
18. Luttges J, Vogel I, Menke M, et al. Clear cell carcinoma of the pancreas: an adenocarcinoma with ductal phenotype. Histopathology. 1998;32:444-448.
19. Mohr VH, Vortmeyer AO, Zhuang Z, et al. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. Am J Pathol. 2000;157:1615-1621.
20. Mount SL, Weaver DL, Taatjes DJ, et al. Von Hippel-Lindau disease presenting as pancreatic neuroendocrine tumour. Virchows Arch. 1995;426:523-528.
21. Musso C, Paraf F, Petit B, et al. Pancreatic neuroendocrine tumors and von Hippel-Lindau disease. Ann Pathol. 2000;20:130-133.
22. Namiq AL, Delcore R, Damjanov I. Pathologic quiz case: clear cell tumor of the pancreas associated with hypercalcemia. Arch Pathol Lab Med. 2003;127:241-242.
23. Nunobe S, Fukushima N, Yachida S, et al. Clear cell endocrine tumor of the pancreas which is not associated with von Hippel-Lindau disease: report of a case. Surg Today. 2003;33:470-474.
24. Ordonez NG, Silva EG. Islet cell tumour with vacuolated lipid-rich cytoplasm: a new histological variant of islet cell tumour. Histopathology. 1997;31:157-160.
25. Pugh CW, Ratcliffe PJ. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol. 2003;13:83-89.
26. Ray S, Lu Z, Rajendiran S. Clear cell ductal adenocarcinoma of pancreas: a case report and review of the literature. Arch Pathol Lab Med. 2004;128:693-696.
27. Ritter JH, Mills SE, Gaffey MJ, et al. Clear cell tumors of the alimentary tract and abdominal cavity. Semin Diagn Pathol. 1997;14:213-219.
28. Sano T, Horiguchi H. Von Hippel-Lindau disease. Microsc Res Tech. 2003;60:159-164.
29. Sinkre PA, Murakata L, Rabin L, et al. Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease. Am J Surg Pathol. 2001;25:1334-1339.
30. Solcia E, Capella C, Kloppel G. Tumors of the pancreas. In: Armed Forces Institute Pathology: Atlas of Tumor Pathology, vol. 20. Washington, DC: American Registry of Pathology, 1997:53-64.
31. Thompson LD, Heffess CS. Renal cell carcinoma to the pancreas in surgical pathology material. Cancer. 2000;89:1076-1088.
32. Tomsova M, Pohnetalova D. Serous microcystic adenoma of the pancreas: cytologic and histologic features. Cesk Patol. 2003;39:163-167.
33. Unger PD, Cohen JM, Thung SN, et al. Lipid degeneration in a pheochromoyctoma histologically mimicking an adrenal cortical tumor. Arch Pathol Lab Med. 1990;114:892-894.
34. Wick MR, Ritter JH, Humphrey PA, et al. Clear cell neoplasms of the endocrine system and thymus. Semin Diagn Pathol. 1997;14:183-202.
35. Yao DX, Soslow RA, Hedvat CV, et al. Melan-A (A103) and inhibin expression in ovarian neoplasms. Appl Immunohistochem Mol Morphol. 2003;11:244-249.
36. Zamboni G, Pea M, Martignoni G, et al. Clear cell 'sugar' tumor of the pancreas: a novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996;20:722-730.